SOMA Research

Peptide Storage and Stability: Oxidation, Freeze-Thaw and Adsorption

A lyophilised peptide looks inert. It is a dry white powder in a sealed vial, and it is easy to treat it as if nothing is happening to it. In practice peptides degrade by several independent routes, and which routes matter depends entirely on the sequence. This guide covers the mechanisms, the handling decisions that follow, and which compounds in the SOMA catalogue are vulnerable to what.

SOMA Research supplies research-use-only compounds for laboratory use. Nothing here is medical advice.

Three independent routes

Chemical degradation changes the molecule: oxidation, deamidation, hydrolysis, aspartimide formation. The product has a different mass or a different structure from the target.

Physical degradation leaves the molecule intact but makes it unavailable: aggregation, precipitation, adsorption to container surfaces. The peptide is still the right peptide; there is just less of it in solution than you think.

Microbial growth applies only to aqueous solutions held above freezing, which is the problem bacteriostatic water exists to address — covered in our reconstitution guide.

These are not alternatives. A badly stored solution can be doing all three at once.

Oxidation: the +16 Da problem

Three residues oxidise readily, and only three matter in practice:

  • Methionine → methionine sulphoxide, +16 Da. The most common degradation product in peptide chemistry. It is reversible in principle and not in practice on a bench. On a reversed-phase trace the sulphoxide is more polar than the parent and elutes earlier, so it appears as a shoulder or a distinct peak ahead of the main one.
  • Cysteine → disulfide. Two cysteines form a bridge, losing 2 Da and potentially dimerising two peptide molecules.
  • Tryptophan. The most photosensitive standard residue; oxidises under light to several products.

A peptide containing none of these three is substantially easier to store, and that is a sequence property you can check before buying. Metal ions accelerate oxidation, which is why chelators appear in some buffer recipes — though not in buffers for GHK-Cu, where a chelator would strip the copper the molecule is built around.

Deamidation and aspartimide: the quiet ones

These are easy to miss because the mass changes barely or not at all.

Deamidation converts asparagine to aspartic acid, or glutamine to glutamic acid, adding 0.98 Da — under one dalton. On a peptide of several thousand daltons that is at or beyond the resolution of routine mass measurement. Rate is strongly sequence-dependent: an Asn followed by Gly deamidates fastest, because the small flexible glycine lets the backbone reach the cyclic intermediate. This is why CJC-1295 carries an Asn→Gln substitution at position 8 — it is a deliberate fix for exactly this.

Aspartimide formation is worse, because the mass does not change at all. An aspartic acid residue cyclises to a five-membered aspartimide ring, which can reopen as either normal aspartate or isoaspartate, where the backbone now runs through the side chain. Same atoms, same mass, different molecule. Mass spectrometry cannot see it. Asp-Gly and Asp-Asp motifs are the usual sites — BPC-157 has an adjacent Asp-Asp pair.

Both are reasons chromatography matters as much as mass confirmation, which our HPLC vs mass spectrometry guide covers in full.

Why freeze-thaw cycling is specifically bad

“Avoid freeze-thaw” appears on every peptide datasheet and is rarely explained. Three things happen when an aqueous solution freezes:

Ice crystals create interfaces. Peptides accumulate at the ice–water boundary, where partial unfolding and aggregation are favoured. Every cycle creates that interface again.

Freeze concentration. Pure water crystallises first, so everything dissolved in it — peptide, buffer salts, any contaminant — is concentrated into a shrinking unfrozen fraction. Local concentrations during freezing can be far above the nominal value, which accelerates any concentration-dependent process, aggregation included.

pH shifts, sometimes dramatically. This is the one most people do not know. In sodium phosphate buffer, the dibasic salt is much less soluble than the monobasic and crystallises out preferentially as the solution freezes. The remaining liquid becomes enriched in the acidic component, and the pH can fall by two units or more during freezing — a buffer nominally at 7.4 can transiently reach the low fours. Potassium phosphate behaves differently and shifts slightly the other way.

So a peptide frozen in sodium phosphate experiences an acid excursion it never sees on the bench. If freezing in solution is necessary, this is a reason to prefer a buffer that does not do it.

The practical answer is simple: aliquot on first reconstitution into single-use volumes, so nothing is frozen and thawed twice.

Physical losses nobody measures

Peptides adsorb to surfaces — polypropylene, glass, pipette tips. At milligram-per-millilitre concentrations the loss is negligible. At nanomolar working concentrations it can be a substantial fraction of the material, and it happens silently: the solution looks identical. Longer and more hydrophobic peptides are worse, so tesamorelin at 44 residues is a greater risk than a tripeptide.

Low-binding plasticware for dilute solutions is the standard mitigation. An unexplained potency drift between a concentrated stock and a dilute working solution is adsorption more often than it is degradation.

Which SOMA compounds are vulnerable to what

Sequence determines risk. This table is derived from the published sequences:

Compound Main vulnerability Why
MOTS-c Highest — oxidation and light Two methionines plus a tryptophan
Semax Oxidation N-terminal methionine
GHK-Cu Light, chelators, pH Copper(II) complex, not a plain peptide
BPC-157 Aspartimide / isoAsp Adjacent Asp-Asp motif
Tesamorelin Aggregation, adsorption 44 residues — longest in the catalogue
NAD+ Alkaline pH, moisture Not a peptide; strongly hygroscopic
Selank, KPV, ipamorelin, CJC-1295 Comparatively robust No Met, Cys or Trp

Note that Selank and Semax came from the same programme and share a stabilising tail, yet sit at opposite ends of this table — Semax has a methionine and Selank does not. Shared design does not mean shared storage behaviour.

Practical summary

  • Lyophilised powder: -20°C, dark, dry. Most peptides are stable for 24 months or more.
  • Before opening: full equilibration to room temperature. Opening a cold vial condenses atmospheric moisture into hygroscopic powder — an irreversible, invisible error.
  • Reconstituted stock: 2–8°C, used within about 30 days.
  • Aliquot immediately into single-use volumes.
  • Light protection is mandatory, not optional, for anything containing tryptophan or a metal complex.
  • Check the buffer against the sequence: no chelators with GHK-Cu, no alkaline conditions with NAD+, no oxidants with methionine-containing peptides.
  • Low-binding plasticware for dilute working solutions.
  • Swirl, do not vortex. Shear and air-liquid interfaces promote aggregation.

Research use only

SOMA Research compounds are supplied for laboratory use by qualified researchers and institutions. They are not manufactured to pharmaceutical standards, have not been approved by the FDA for any use, and must not be used in or on humans or animals.